{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:08:37Z","timestamp":1793210917610,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Forskningsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["UKDRI-1003"],"award-info":[{"award-number":["UKDRI-1003"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["-201809\\u20132016615"],"award-info":[{"award-number":["-201809\\u20132016615"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ZEN-21-848495"],"award-info":[{"award-number":["ZEN-21-848495"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["SG-23-1038904 QC"],"award-info":[{"award-number":["SG-23-1038904 QC"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AG068398-01"],"award-info":[{"award-number":["1R01AG068398-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["JPND2021-00694"],"award-info":[{"award-number":["JPND2021-00694"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["JPND2019-466-236"],"award-info":[{"award-number":["JPND2019-466-236"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007436","name":"Erling Persson Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010815","name":"Stiftelsen F\u00f6r Gamla Tj\u00e4narinnor","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013263","name":"Nasjonalforeningen for Folkehelsen","doi-asserted-by":"publisher","award":["1513"],"award-info":[{"award-number":["1513"]}],"id":[{"id":"10.13039\/501100013263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013263","name":"Nasjonalforeningen for Folkehelsen","doi-asserted-by":"publisher","award":["14845"],"award-info":[{"award-number":["14845"]}],"id":[{"id":"10.13039\/501100013263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013263","name":"Nasjonalforeningen for Folkehelsen","doi-asserted-by":"publisher","award":["25633"],"award-info":[{"award-number":["25633"]}],"id":[{"id":"10.13039\/501100013263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["-930351"],"award-info":[{"award-number":["-930351"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["2017-0243"],"award-info":[{"award-number":["2017-0243"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["-968270"],"award-info":[{"award-number":["-968270"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["-939721"],"award-info":[{"award-number":["-939721"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["2022-0006"],"award-info":[{"award-number":["2022-0006"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer&apos;s Association","doi-asserted-by":"publisher","award":["-21\\u2013831381-C"],"award-info":[{"award-number":["-21\\u2013831381-C"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer&apos;s Association","doi-asserted-by":"publisher","award":["-21\\u2013831376-C"],"award-info":[{"award-number":["-21\\u2013831376-C"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer&apos;s Association","doi-asserted-by":"publisher","award":["ZEN-21-848495"],"award-info":[{"award-number":["ZEN-21-848495"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer&apos;s Association","doi-asserted-by":"publisher","award":["SG-23-1038904 QC"],"award-info":[{"award-number":["SG-23-1038904 QC"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer&apos;s Association","doi-asserted-by":"publisher","award":["#ADSF-21-831377-C"],"award-info":[{"award-number":["#ADSF-21-831377-C"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["725025"],"award-info":[{"award-number":["725025"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["771375"],"award-info":[{"award-number":["771375"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["283634"],"award-info":[{"award-number":["283634"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer&apos;s Drug Discovery Foundation","doi-asserted-by":"publisher","award":["201809-2016862"],"award-info":[{"award-number":["201809-2016862"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2017-00915"],"award-info":[{"award-number":["2017-00915"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2022-00732"],"award-info":[{"award-number":["2022-00732"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2018-02532"],"award-info":[{"award-number":["2018-02532"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021720","name":"Olav Thon Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2017095"],"award-info":[{"award-number":["2017095"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"Horizon 2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["860197"],"award-info":[{"award-number":["860197"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.neurobiolaging.2023.05.012","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T11:19:49Z","timestamp":1685359189000},"page":"11-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Matrix metalloproteinases are associated with brain atrophy in cognitively unimpaired individuals"],"prefix":"10.1016","volume":"131","author":[{"given":"Mari","family":"Aksnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elettra","family":"Capogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didac","family":"Vidal-Pi\u00f1eiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrukh Abbas","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Myrstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane-Victoria","family":"Idland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie Bodd","family":"Halaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shams","family":"Dakhil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine Beate","family":"Walhovd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiv Otto","family":"Watne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Martin","family":"Fjell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2023.05.012_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116989","volume":"416","author":"Abe","year":"2020","journal-title":"J. Neurol. Sci"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2023.05.012_bib2","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/labinvest.2009.101","article-title":"Timp-3 deficiency impairs cognitive function in mice","volume":"89","author":"Baba","year":"2009","journal-title":"Lab. Invest."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2023.05.012_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J. Stat. Softw."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2023.05.012_bib4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3233\/JAD-2011-110566","article-title":"Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease","volume":"27","author":"Bjerke","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2023.05.012_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3233\/JAD-201565","article-title":"Different inflammatory signatures in Alzheimer's disease and frontotemporal dementia cerebrospinal fluid","volume":"81","author":"Bostr\u00f6m","year":"2021","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2023.05.012_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2010.01.003","article-title":"The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity","volume":"1803","author":"Brew","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2023.05.012_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/620581","article-title":"Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases","volume":"2015","author":"Brkic","year":"2015","journal-title":"Mediators Inflamm."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2023.05.012_bib8","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.11.002","article-title":"White matter hyperintensity volume correlates with matrix metalloproteinase-2 in acute ischemic stroke","volume":"23","author":"Corbin","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2023.05.012_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/nimg.1998.0395","article-title":"Cortical surface-based analysis. I. Segmentation and surface reconstruction","volume":"9","author":"Dale","year":"1999","journal-title":"Neuroimage"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2023.05.012_bib10","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.neurobiolaging.2005.08.013","article-title":"Gene expression correlates of neurofibrillary tangles in Alzheimer's disease","volume":"27","author":"Dunckley","year":"2006","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2023.05.012_bib11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2217\/bmm.12.42","article-title":"Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease","volume":"6","author":"Fagan","year":"2012","journal-title":"Biomark. Med."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2023.05.012_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/nimg.1998.0396","article-title":"Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system","volume":"9","author":"Fischl","year":"1999","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2023.05.012_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1515\/REVNEURO.2010.21.3.187","article-title":"Structural brain changes in aging: courses, causes and cognitive consequences","volume":"21","author":"Fjell","year":"2010","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2023.05.012_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pneurobio.2014.02.004","article-title":"What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus","volume":"117","author":"Fjell","year":"2014","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2023.05.012_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2023.05.012_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1515\/cclm-2021-0651","article-title":"Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid","volume":"60","author":"Gobom","year":"2022","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.neurobiolaging.2023.05.012_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2016.44","article-title":"The brain imaging data structure, a format for organizing and describing outputs of neuroimaging experiments","volume":"3","author":"Gorgolewski","year":"2016","journal-title":"Sci Data."},{"key":"10.1016\/j.neurobiolaging.2023.05.012_bib18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.matbio.2017.11.007","article-title":"The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes","volume":"75\u201376","author":"Hannocks","year":"2019","journal-title":"Matrix Biol."},{"issue":"24","key":"10.1016\/j.neurobiolaging.2023.05.012_bib19","doi-asserted-by":"crossref","first-page":"15078","DOI":"10.1074\/jbc.M114.610931","article-title":"Sequential amyloid-\u03b2 degradation by the matrix metalloproteases MMP-2 and MMP-9","volume":"290","author":"Hernandez-Guillamon","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"40","key":"10.1016\/j.neurobiolaging.2023.05.012_bib20","doi-asserted-by":"crossref","first-page":"10895","DOI":"10.1523\/JNEUROSCI.3135-07.2007","article-title":"The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis","volume":"27","author":"Hoe","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2023.05.012_bib21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neurobiolaging.2016.09.012","article-title":"CSF neurofilament light levels predict hippocampal atrophy in cognitively healthy older adults","volume":"49","author":"Idland","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2023.05.012_bib22","doi-asserted-by":"crossref","first-page":"14324","DOI":"10.1038\/s41598-021-93498-w","article-title":"New candidate blood biomarkers potentially associated with white matter hyperintensities progression","volume":"11","author":"Jim\u00e9nez-Balado","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2023.05.012_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1471-4159.2010.07082.x","article-title":"Role of matrix metalloproteinase-3 in neurodegeneration","volume":"116","author":"Kim","year":"2011","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2023.05.012_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.expneurol.2004.10.014","article-title":"Elevation of hippocampal MMP-3 expression and activity during trauma-induced synaptogenesis","volume":"192","author":"Kim","year":"2005","journal-title":"Exp. Neurol."},{"issue":"3\u20134","key":"10.1016\/j.neurobiolaging.2023.05.012_bib25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000362876","article-title":"Circulating matrix metalloproteinase-9 level is associated with cerebral white matter hyperintensities in non-stroke individuals","volume":"72","author":"Kim","year":"2014","journal-title":"Eur. Neurol."},{"issue":"13","key":"10.1016\/j.neurobiolaging.2023.05.012_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v082.i13","article-title":"lmerTest package: tests in linear mixed effects models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J. Stat. Softw."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2023.05.012_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219165","article-title":"The effect of aging in primary human dermal fibroblasts","volume":"14","author":"Lago","year":"2019","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.neurobiolaging.2023.05.012_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-510X(02)00398-2","article-title":"Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases","volume":"207","author":"Lorenzl","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2023.05.012_bib29","unstructured":"L\u00fcdecke, D., 2022. sjPlot: data visualization for statistics in social science, 2.8.12 ed."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2023.05.012_bib30","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/brain\/awac024","article-title":"Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer\u2019s type","volume":"145","author":"Martino Adami","year":"2022","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2023.05.012_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.69","article-title":"CSF protein biomarkers predicting longitudinal reduction of CSF \u03b2-amyloid42 in cognitively healthy elders","volume":"3","author":"Mattsson","year":"2013","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2023.05.012_bib32","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.neurobiolaging.2013.08.027","article-title":"Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults","volume":"35","author":"Mattsson","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2023.05.012_bib33","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1471-4159.2005.03565.x","article-title":"Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity","volume":"96","author":"Meighan","year":"2006","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2023.05.012_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neulet.2009.09.043","article-title":"Matrix metalloproteinases-2 and -3 are reduced in cerebrospinal fluid with low beta-amyloid1\u201342 levels","volume":"466","author":"Mlekusch","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2023.05.012_bib35","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2005.10.070","article-title":"C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis","volume":"47","author":"Montero","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.neurobiolaging.2023.05.012_bib36","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease","volume":"39","author":"Morris","year":"1989","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2023.05.012_bib37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3233\/JAD-131634","article-title":"Concentrations of matrix metalloproteinases and their tissue inhibitors in the cerebrospinal fluid of patients with Alzheimer's disease","volume":"40","author":"Mroczko","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2023.05.012_bib38","first-page":"400","article-title":"Correlations between MMP-2\/MMP-9 promoter polymorphisms and ischemic stroke","volume":"7","author":"Nie","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2023.05.012_bib39","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.expneurol.2012.07.018","article-title":"Limited cleavage of tau with matrix-metalloproteinase MMP-9, but not MMP-3, enhances tau oligomer formation","volume":"237","author":"N\u00fcbling","year":"2012","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2023.05.012_bib40","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/glia.20478","article-title":"Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia","volume":"55","author":"Nuttall","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.neurobiolaging.2023.05.012_bib41","unstructured":"R Core Team. 2022. R: a language and environment for statistical computing. R Foundation for Statistical Computing."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2023.05.012_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172234","article-title":"Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas","volume":"12","author":"Ramachandran","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2023.05.012_bib43","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the Trail Making Test as an indicator of organic brain damage","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept. Mot. Skills"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2023.05.012_bib44","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0271678X16655551","article-title":"Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers","volume":"36","author":"Rempe","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2023.05.012_bib45","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.neuroimage.2010.07.020","article-title":"Highly accurate inverse consistent registration: a robust approach","volume":"53","author":"Reuter","year":"2010","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2023.05.012_bib46","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.neuroimage.2012.02.084","article-title":"Within-subject template estimation for unbiased longitudinal image analysis","volume":"61","author":"Reuter","year":"2012","journal-title":"Neuroimage"},{"issue":"16","key":"10.1016\/j.neurobiolaging.2023.05.012_bib47","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1007\/s00018-019-03178-2","article-title":"Metalloproteinases and their tissue inhibitors in Alzheimer\u2019s disease and other neurodegenerative disorders","volume":"76","author":"Rivera","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"46","key":"10.1016\/j.neurobiolaging.2023.05.012_bib48","doi-asserted-by":"crossref","first-page":"15337","DOI":"10.1523\/JNEUROSCI.3467-10.2010","article-title":"Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?","volume":"30","author":"Rivera","year":"2010","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.neurobiolaging.2023.05.012_bib49","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.neurobiolaging.2008.11.004","article-title":"Association of matrix metalloproteinases with MRI indices of brain ischemia and aging","volume":"31","author":"Romero","year":"2010","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2023.05.012_bib50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1474-4422(09)70016-X","article-title":"Matrix metalloproteinases and their multiple roles in neurodegenerative diseases","volume":"8","author":"Rosenberg","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2023.05.012_bib51","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.bbi.2020.03.014","article-title":"TIMP-1: A key cytokine released from activated astrocytes protects neurons and ameliorates cognitive behaviours in a rodent model of Alzheimer's disease","volume":"87","author":"Saha","year":"2020","journal-title":"Brain. Behav. Immun."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2023.05.012_bib52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12883-020-1608-8","article-title":"Inflammation biomarker discovery in Parkinson\u2019s disease and atypical parkinsonisms","volume":"20","author":"Santaella","year":"2020","journal-title":"BMC Neurol."},{"issue":"9","key":"10.1016\/j.neurobiolaging.2023.05.012_bib53","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/NEN.0b013e3182294fad","article-title":"Matrix metalloproteinases and their tissue inhibitors in cuprizone-induced demyelination and remyelination of brain white and gray matter","volume":"70","author":"Skuljec","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2023.05.012_bib54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/alzrt44","article-title":"Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease","volume":"2","author":"Stomrud","year":"2010","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2023.05.012_bib55","series-title":"A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary","author":"Strauss","year":"2006"},{"issue":"5a","key":"10.1016\/j.neurobiolaging.2023.05.012_bib56","first-page":"3937","article-title":"Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas","volume":"23","author":"Thorns","year":"2003","journal-title":"Anticancer Res."},{"key":"10.1016\/j.neurobiolaging.2023.05.012_bib57","unstructured":"Wei, T., Simko, V., 2021. R package 'corrplot': visualization of a correlation matrix, version 0.92 ed."},{"key":"10.1016\/j.neurobiolaging.2023.05.012_bib58","series-title":"ggplot2: Elegant Graphics for Data Analysis, R package version 3.2.1 ed","author":"Wickham","year":"2016"},{"issue":"34","key":"10.1016\/j.neurobiolaging.2023.05.012_bib59","doi-asserted-by":"crossref","first-page":"24566","DOI":"10.1074\/jbc.M602440200","article-title":"Matrix metalloproteinase-9 degrades amyloid-\u03b2 fibrils in vitro and compact plaques in situ","volume":"281","author":"Yan","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2023.05.012_bib60","first-page":"1826","article-title":"MMP-2 expression and correlation with pathology and MRI of glioma","volume":"17","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458023001045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458023001045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:51:20Z","timestamp":1777528280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458023001045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":60,"alternative-id":["S0197458023001045"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2023.05.012","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Matrix metalloproteinases are associated with brain atrophy in cognitively unimpaired individuals","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2023.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}